Search Results

Utah Medical Products, Inc. announces that its Board of Directors approved a quarterly cash dividend of thirty cents per share of common stock payable on April 3, 2024 to stockholders of record at the close of business on March 15, 2024.

Surmodics, Inc. announced it has been awarded a group purchasing agreement for thrombectomy products with Premier, Inc. Effective June 1, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Surmodics Pounce™ and Pounce™ Venous Thrombectomy Systems.

Product Creation Studio, a premier provider of engineering and design services, is excited to announce a new partnership with PatchClamp Medtech Inc.

Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.

Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.

Biosenta Inc. (CSE: ZRO) (“Biosenta” or the “Company”), a leader in developing eco-friendly antimicrobial compounds, is pleased to announce significant advancements at its state-of-the-art bench scale production

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc.

Accuray Incorporated announced that the registration dossier for the Accuray Precision® Treatment Planning System has been approved by the Chinese National Medical Products Administration.

Nika Pharmaceuticals, Inc. announces that it is the beneficial owner of a production building and land valued at $2,045,209, located in Sofia Province, Bulgaria.